Atrys Health, S.A. (ATRY.MC)

EUR 2.85

(0.35%)

Net Debt Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual net debt in 2023 was 212.17 Million EUR , down -5.47% from previous year.
Atrys Health, S.A.'s latest quarterly net debt in 2024 Q1 was 156.32 Million EUR , down -26.32% from previous quarter.
Atrys Health, S.A. reported annual net debt of 224.44 Million EUR in 2022, up 32.5% from previous year.
Atrys Health, S.A. reported annual net debt of 169.38 Million EUR in 2021, up 213.8% from previous year.
Atrys Health, S.A. reported quarterly net debt of 156.32 Million EUR for 2024 Q1, down -26.32% from previous quarter.
Atrys Health, S.A. reported quarterly net debt of 205.66 Million EUR for 2023 Q3, down -13.89% from previous quarter.

Annual Net Debt Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Net Debt of Atrys Health, S.A. (2023 - 2012)

Year	Net Debt	Net Debt Growth
2023	212.17 Million EUR	-5.47%
2022	224.44 Million EUR	32.5%
2021	169.38 Million EUR	213.8%
2020	53.97 Million EUR	103.91%
2019	26.47 Million EUR	214.06%
2018	8.42 Million EUR	339.17%
2017	1.91 Million EUR	-82.24%
2016	10.8 Million EUR	-13.41%
2015	12.48 Million EUR	15.34%
2014	10.82 Million EUR	6.39%
2013	10.17 Million EUR	-0.44%
2012	10.21 Million EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	207.34 Million EUR	52.4%
2024 Q1	156.32 Million EUR	-26.32%
2023 Q3	205.66 Million EUR	-13.89%
2023 FY	212.17 Million EUR	-5.47%
2023 Q1	233.14 Million EUR	3.88%
2023 Q4	212.17 Million EUR	3.16%
2023 Q2	238.84 Million EUR	2.44%
2022 Q1	200.19 Million EUR	18.19%
2022 FY	224.44 Million EUR	32.5%
2022 Q4	224.44 Million EUR	12.51%
2022 Q3	199.48 Million EUR	-3.21%
2022 Q2	206.09 Million EUR	2.95%
2021 Q4	169.38 Million EUR	6.36%
2021 Q1	161.74 Million EUR	199.64%
2021 FY	169.38 Million EUR	213.8%
2021 Q2	166.79 Million EUR	3.12%
2021 Q3	159.25 Million EUR	-4.52%
2020 Q2	31.05 Million EUR	2.11%
2020 Q4	53.97 Million EUR	1.46%
2020 Q1	30.41 Million EUR	14.9%
2020 FY	53.97 Million EUR	103.91%
2020 Q3	53.2 Million EUR	71.32%
2019 FY	26.47 Million EUR	214.06%
2019 Q2	19.34 Million EUR	2.18%
2019 Q4	26.47 Million EUR	-1.12%
2019 Q3	26.77 Million EUR	38.36%
2019 Q1	18.93 Million EUR	124.65%
2018 Q4	8.42 Million EUR	4.39%
2018 FY	8.42 Million EUR	339.17%
2018 Q2	-8.23 Million EUR	-525.05%
2018 Q1	1.93 Million EUR	0.88%
2018 Q3	8.07 Million EUR	198.11%
2017 FY	1.91 Million EUR	-82.24%
2017 Q4	1.91 Million EUR	-43.86%
2017 Q3	3.41 Million EUR	-72.27%
2017 Q2	12.32 Million EUR	1.29%
2017 Q1	12.17 Million EUR	12.62%
2016 Q2	1.98 Million EUR	0.17%
2016 Q1	1.98 Million EUR	0.0%
2016 FY	10.8 Million EUR	-13.41%
2016 Q4	10.8 Million EUR	1.65%
2016 Q3	10.63 Million EUR	435.04%
2015 FY	12.48 Million EUR	15.34%
2014 FY	10.82 Million EUR	6.39%
2013 FY	10.17 Million EUR	-0.44%
2012 FY	10.21 Million EUR	0.0%

Peer Net Debt Comparison of Atrys Health, S.A.

Name	Net Debt	Net Debt Difference
Biotechnologies Assets SA	6.81 Million EUR	-3013.449%
Oryzon Genomics S.A.	1.43 Million EUR	-14733.668%
Pharma Mar, S.A.	-16.65 Million EUR	1373.841%
Laboratorios Farmaceuticos Rovi, S.A.	40.1 Million EUR	-429.039%